Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment.

Cancer · 2014 · Benefit · Low evidence

← Research stream

BenefitLow evidencePaper 3117

Study snapshot

PublicationCancer · 2014

Study typeanimal

Reported directionBenefit

Evidence ratingLow

Abstract

BACKGROUND: Patients with pancreatic ductal adenocarcinoma (PDAC) have limited therapeutic options and poor response to the standard gemcitabine (GCB)-based chemotherapy. In the current study, the authors investigated the feasibility of noninvasive short-wave radiofrequency (RF) electric fields to improve the cytotoxic effect of GCB on PDAC cells and determined its mechanism of action. METHODS: The cytotoxicity of RF alone and in combination with GCB was studied in vitro on normal pancreatic human pancreatic ductal epithelial cells and different PDAC cell lines by flow cytometry, and in vivo on ectopic and orthotopic human PDAC xenograft models in mice. The mechanism of RF activity was studied by Western blot analysis and immunohistochemistry. Toxicity was determined by histopathology. RESULTS: Exposure of different PDAC cells to 13.56-megahertz radio waves resulted in a substantial cytotoxic effect, which was accompanied by the induction of autophagy but not apoptosis. These effects of RF were found to be absent in normal cells. Excessive numbers of autophagosomes in cancer cells persisted 24 to 48 hours after RF exposure and then declined. The addition of a subtoxic dose of GCB to RF treatment inhibited the recovery of cancer cells from the RF-induced autophagy and enhanced the cytotoxic effect of the latter on cancer cells. The treatment of PDAC in situ in mice with the combination of noninvasive RF and GCB was found to have a superior antitumor effect compared with the use of RF or GCB alone, yet there was no evidence of systemic toxicity. CONCLUSIONS: Noninvasive RF treatment induced autophagy but not apoptosis in cancer cells and demonstrated potential as an enhancer of chemotherapy for treating patients with pancreatic cancer without toxicity to normal cells.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typeanimal

Effect directionbenefit

PopulationHuman pancreatic ductal epithelial cells and pancreatic ductal adenocarcinoma (PDAC) cell lines (in vitro); human PDAC xenograft models in mice (in vivo)

Sample sizeNot supplied

ExposureRF · 13.56 MHz

Evidence strengthLowConfidence: 78% · Peer reviewed: yes

Main findings

Exposure of PDAC cells to 13.56 MHz radio waves produced substantial cytotoxicity accompanied by induction of autophagy but not apoptosis; these effects were reported as absent in normal pancreatic ductal epithelial cells. Combining RF with a subtoxic dose of gemcitabine inhibited recovery from RF-induced autophagy and enhanced cytotoxicity in vitro, and showed superior antitumor effects versus RF or gemcitabine alone in mouse PDAC xenografts without evidence of systemic toxicity.

Outcomes measured

Cytotoxicity/cell death
Autophagy induction
Apoptosis markers
Tumor response/antitumor effect in xenograft models
Systemic toxicity (histopathology)

Limitations

Sample size not reported in abstract
Exposure metrics beyond frequency (e.g., field strength, SAR, duration) not provided in abstract
Preclinical design (cell lines and mouse xenografts) limits direct inference to clinical outcomes

View raw extracted JSON

{
  "study_type": "animal",
  "exposure": {
    "band": "RF",
    "source": "other",
    "frequency_mhz": 13.56,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Human pancreatic ductal epithelial cells and pancreatic ductal adenocarcinoma (PDAC) cell lines (in vitro); human PDAC xenograft models in mice (in vivo)",
  "sample_size": null,
  "outcomes": [
    "Cytotoxicity/cell death",
    "Autophagy induction",
    "Apoptosis markers",
    "Tumor response/antitumor effect in xenograft models",
    "Systemic toxicity (histopathology)"
  ],
  "main_findings": "Exposure of PDAC cells to 13.56 MHz radio waves produced substantial cytotoxicity accompanied by induction of autophagy but not apoptosis; these effects were reported as absent in normal pancreatic ductal epithelial cells. Combining RF with a subtoxic dose of gemcitabine inhibited recovery from RF-induced autophagy and enhanced cytotoxicity in vitro, and showed superior antitumor effects versus RF or gemcitabine alone in mouse PDAC xenografts without evidence of systemic toxicity.",
  "effect_direction": "benefit",
  "limitations": [
    "Sample size not reported in abstract",
    "Exposure metrics beyond frequency (e.g., field strength, SAR, duration) not provided in abstract",
    "Preclinical design (cell lines and mouse xenografts) limits direct inference to clinical outcomes"
  ],
  "evidence_strength": "low",
  "confidence": 0.78,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "radiofrequency",
    "13.56 MHz",
    "short-wave",
    "electric fields",
    "pancreatic ductal adenocarcinoma",
    "gemcitabine",
    "chemosensitization",
    "autophagy",
    "xenograft",
    "noninvasive"
  ],
  "suggested_hubs": [
    {
      "slug": "rf-cancer-therapy",
      "weight": 0.9,
      "reason": "Study evaluates noninvasive RF electric fields as an antitumor/chemosensitizing treatment in pancreatic cancer models."
    }
  ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.1002/cncr.28453
PubMed: 24496866

Read the original paper →

Related papers

← Back to the Research Library